Biomarker-directed, multi-drug, phase 1b trial in bladder cancer | Dr Hendrik-Tobias Arkenau at ECC 2015

At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses an open-label, biomarker-directed, multi-drug, multi-centre, m... Author: EMJ Added: 10/17/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts